Company Quest PharmaTech Inc. Other OTC

Stocks

QPTFF

CA74836M1068

Biotechnology & Medical Research

Business description: Quest PharmaTech Inc.

Sales by Activity: Quest PharmaTech Inc.

Executive Committee: Quest PharmaTech Inc.

Composition of the Board of Directors: Quest PharmaTech Inc.

Shareholders: Quest PharmaTech Inc.

Company details: Quest PharmaTech Inc.

Other Biotechnology & Medical Research

Sector

Inactive Instrument

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuestâ€™s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)

See all business segments

Manager	Title	Age	Since
Ragupathy Madiyalakan CEO	Chief Executive Officer	-	17/06/2004
Pierre Vermette DFI	Director of Finance/CFO	-	01/01/2005

See QUEST PHARMATECH INC. governance

Director	Title	Age	Since
Ragupathy Madiyalakan BRD	Director/Board Member	-	17/06/2004
J. Lievonen CHM	Chairman	-	05/07/2021
Jeffrey Shon BRD	Director/Board Member	-	05/07/2021
Bradley J Glass BRD	Director/Board Member	-	-

Composition of the Board of Directors

Name	Stocks	%	Valuation
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 14.78 %	25,000,000	14.78 %	450 000 $
Ragupathy Madiyalakan 1.892 %	3,200,000	1.892 %	57 600 $
Pierre Vermette 1.042 %	1,761,518	1.042 %	31 707 $
Jeffrey Shon 0.2069 %	350,000	0.2069 %	6 300 $
J. Lievonen 0 %	0	0 %	- $

List of QUEST PHARMATECH INC. shareholders

Quest PharmaTech, Inc.

97 Street NW

T6E 5R9, Edmonton

http://www.questpharmatech.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.68%	-0.68%	-1.63%	+12.86%	48.22B
REVOLUTION MEDICINES, INC.	+6.03%	+5.22%	+420.33%	+519.87%	38.79B
IQVIA HOLDINGS INC.	-2.21%	-6.07%	+24.87%	+5.20%	38.41B
BEONE MEDICINES AG	+2.94%	-2.25%	+6.15%	+59.69%	34.88B
CELLTRION, INC.	+1.98%	+4.74%	+12.19%	+41.37%	29.19B
ASCENDIS PHARMA A/S	+0.47%	-3.87%	-	-	16.05B
MEDPACE HOLDINGS, INC.	+0.31%	+0.72%	+32.99%	+122.25%	16B
EUROFINS SCIENTIFIC SE	+1.59%	+0.44%	+3.43%	+16.80%	13.53B
ICON PUBLIC LIMITED COMPANY	-0.98%	-12.98%	-4.82%	-38.09%	12.22B
Average	+1.05%	+0.01%	+61.69%	+92.49%	27.48B
Weighted average by Cap.	+1.21%	+1.55%	+78.99%	+112.40%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research